[VSsupport]

<img alt="" height="1" width="1" />Ironwood Pharmaceuticals, Imperial Capital Test the IPO WatersSeeking Alpha (blog)Linaclotide was developed for those who suffer from irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC), two ailments that ...Ironwood Seeks 15% IPO Premium as Investors Lose in New Deals<nobr>BusinessWeek</nobr>IPO On Tap, Ironwood Aims for Big Pharma<nobr>Minyanville.com</nobr>Ironwood Gears Up for Biotech's Biggest IPO in Years, Sending Ripple Effect ...<nobr>Xconomy</nobr><nobr>Seeking Alpha (blog)</nobr><nobr>all 12 news articles »</nobr>

View the full article